Prevalence of HTLV-III Infection among New Haven, Connecticut, Parenteral Drug Abusers in 1982–1983

R. D'Aquila, A. B. Williams, H. D. Kleber, A. E. Williams

Research output: Contribution to journalLetterpeer-review

17 Scopus citations

Abstract

To the Editor: The acquired immunodeficiency syndrome (AIDS) is etiologically linked to human T-cell lymphotropic virus Type III (HTLV-III). Intravenous drug use is the primary known risk factor in 17 percent of U.S. cases of AIDS.1 We now report that the presence of HTLV-III antibody was confirmed by Western blot assay in at least 10 percent of a group of New Haven, Connecticut, parenteral drug abusers in 1982–1983. We also question the adequacy of using only enzyme-linked immunosorbent assay (ELISA) testing in this risk group. Serum specimens were collected from 283 persons presenting to the medical unit of the substance-abuse…

Original languageEnglish (US)
Pages (from-to)117-118
Number of pages2
JournalNew England Journal of Medicine
Volume314
Issue number2
DOIs
StatePublished - Jan 9 1986

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Prevalence of HTLV-III Infection among New Haven, Connecticut, Parenteral Drug Abusers in 1982–1983'. Together they form a unique fingerprint.

Cite this